Please provide your email address to receive an email when new articles are posted on . 37.4% of patients with Fitzpatrick skin types IV to VI and 38.7% of the total ...
HORSHAM, Pa., June 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...
Panelists discuss how recent clinical trials like ADmirable and DISCOVER intentionally enrolled patients with skin of color (Fitzpatrick types IV-VI), demonstrating similar efficacy and safety ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results